dr. reddy's labs glp-1 receptor agonist medications With the launch of Obeda®, India's first DCGI-approved semaglutide injection for Type 2 Diabetes, we are excited to support diabetes care in India with high-quality, accessible and affordable treatment. In a head-to-head A Comprehensive Review of the

India stands tall as the worlds pharmacy now poised to lead the GLP-1 revolution

Learn more about its role in diabetes management.

Incorporating this botanical product into a balanced diet supports healthy metabolism as well as regular digestive and muscle function without risking undernutrition.*

Designed to complement your GLP-1 journey

A recent study, published in the Journal of Pharmacy and Pharmacology Research, sugges

In this attempt, observational and experimental studies and review articles will be gathered from leading scientists in the field of diabetes mellitus.Areas to be covered in this Research Topic may include, but are not limited to:- Studies on the effect of SGLT2 inhibitors or GLP-1 receptor agonists on testosterone and gonadotropins in male patients with diabetes mellitus and hypogonadism- Studies on the effect of SGLT2 inhibitors or GLP-1 receptor agonists on testosterone gonadotropins in female patients with diabetes mellitus and p...